Cargando…
A Pilot Analysis of Circulating cfRNA Transcripts for the Detection of Lung Cancer
Lung cancers are the leading cause of cancer-related deaths worldwide. Studies have shown that non-small cell lung cancer (NSCLC), which constitutes the majority of lung cancers, is significantly more responsive to early-stage interventions. However, the early stages are often asymptomatic, and curr...
Autores principales: | Seneviratne, Chamindi, Shetty, Amol Carl, Geng, Xinyan, McCracken, Carrie, Cornell, Jessica, Mullins, Kristin, Jiang, Feng, Stass, Sanford |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776862/ https://www.ncbi.nlm.nih.gov/pubmed/36552904 http://dx.doi.org/10.3390/diagnostics12122897 |
Ejemplares similares
-
Decoding cell-type contributions to the cfRNA transcriptomic landscape of liver cancer
por: Safrastyan, Aram, et al.
Publicado: (2023) -
Using cfRNA as a tool to evaluate clinical treatment outcomes in patients with metastatic lung cancers and other tumors
por: Raez, Luis E., et al.
Publicado: (2021) -
The clinical utility of cfRNA for disease detection and surveillance: A proof of concept study in non‐small cell lung cancer
por: Metzenmacher, Martin, et al.
Publicado: (2022) -
Adaptor Template Oligo-Mediated Sequencing (ATOM-Seq) is a new ultra-sensitive UMI-based NGS library preparation technology for use with cfDNA and cfRNA
por: Dunwell, Thomas L., et al.
Publicado: (2021) -
Multigene PCR using both cfDNA and cfRNA in the supernatant of pleural effusion achieves accurate and rapid detection of mutations and fusions of driver genes in patients with advanced NSCLC
por: Chen, Xuejing, et al.
Publicado: (2021)